# Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear

> **NCT02412059** · NA · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 200 (actual)

## Conditions studied

- Epiretinal Membrane

## Interventions

- **DRUG:** Prednisolone acetate

## Key facts

- **NCT ID:** NCT02412059
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2016-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412059, "Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02412059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*